LYMPHOSCORE (Lymphoscintigraphy Scoring Reliability) Reliability of a New Qualitative and Semiquantitative Lymphoscintigraphy Scoring System for Primary Lymphedema.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
25 Jun 2024
25 Jun 2024
Historique:
medline:
25
6
2024
pubmed:
25
6
2024
entrez:
25
6
2024
Statut:
aheadofprint
Résumé
Primary lymphedema (PLE) is a rare chronic disorder. Extremity lymphoscintigraphy offers access for dynamic and functional information on peripheral lymphatics and lymph nodes. We aimed to assess intraobserver and interobserver reliability of a new lymphoscintigraphy quantitative and qualitative scoring system in a homogeneous population of adult patients followed for PLE of the lower limb(s). This is a monocentric retrospective study. Clinical files of patients who underwent a lymphoscintigraphy were reviewed for inclusion. Lymphoscintigraphies were interpreted twice by 2 observers with a washout period. To assess intraobserver and interobserver reliability for both lower limbs, Cohen κ and Gwet's AC1 reliability coefficients were calculated with 95% confidence interval and P value of the zero-reliability comparison test. To interpret reliability coefficients, we used the orders of magnitude reported by Landis and Koch. One hundred forty-four patients (288 limbs) with PLE were included. For intraobserver reliability, agreement range was 0.87-1 with an almost perfect agreement in all staging items of the score for both limbs with the lower limit of the 95% confidence interval ≥80%. Interobserver reliability was overall strong or almost perfect, ranging from 0.67 to 0.97. This new scoring system demonstrated excellent intraobserver reliability and a very good interobserver reliability. Lymphoscintigraphy, when performed in a referral center and interpreted by trained nuclear medicine physicians, is a reliable means of investigation in patients with PLE of the lower limbs. This reproducibility advocates for further use of lymphoscintigraphy in multicentric cohorts of PLE patients.
Identifiants
pubmed: 38915154
doi: 10.1097/RLU.0000000000005357
pii: 00003072-990000000-01192
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics. 1985;76:206–218.
Erickson RP, Lai LW, Mustacich DJ, et al. Sex-limited penetrance of lymphedema to females with CELSR1 haploinsufficiency: a second family. Clin Genet. 2019;96:478–482.
Fastre E, Lanteigne LE, Helaers R, et al. Splice-site mutations in VEGFC cause loss of function and Nonne-Milroy-like primary lymphedema. Clin Genet. 2018;94:179–181.
Kinmonth JB, Harper RA, Taylor GW. Lymphangiography by radiological methods. J Fac Radiol. 1955;6:217–223.
Kinmonth JB, Taylor GW, Harper RK. Lymphangiography; a technique for its clinical use in the lower limb. Br Med J. 1955;1:940–942.
Nawaz MK, Hamad MM, Abdel-Dayem HM, et al. Tc-99m human serum albumin lymphoscintigraphy in lymphedema of the lower extremities. Clin Nucl Med. 1990;15:794–799.
Kramer EL. Lymphoscintigraphy: radiopharmaceutical selection and methods. Int J Rad Appl Instrum B. 1990;17:57–63.
Suga K, Kume N, Matsunaga N, et al. Assessment of leg oedema by dynamic lymphoscintigraphy with intradermal injection of technetium-99m human serum albumin and load produced by standing. Eur J Nucl Med. 2001;28:294–303.
Szuba A, Shin WS, Strauss HW, et al. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43–57.
Sarica M, Gordon K, van Zanten M, et al. Lymphoscintigraphic abnormalities associated with Milroy disease and lymphedema-distichiasis syndrome. Lymphat Res Biol. 2019;17:610–619.
Kleinhans E, Baumeister RG, Hahn D, et al. Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted lymphatic vessels. Eur J Nucl Med. 1985;10:349–352.
Cambria RA, Gloviczki P, Naessens JM, et al. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities. J Vasc Surg. 1993;18:773–782.
Szuba A, Strauss W, Sirsikar SP, et al. Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer–related lymphedema of the upper extremity. Nucl Med Commun. 2002;23:1171–1175.
Constans J. Les Explorations Vasculaires. Paris, France: Elsevier Masson; 2014.
International Society of L. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the International Society of Lymphology. Lymphology. 2013;46:1–11.
Executive Committee of the International Society of L. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the International Society of Lymphology. Lymphology. 2020;53:3–19.
Franco ACM, Beani JC, Doucet J, et al. La lymphoscintigraphie indirecte. Son intérêt pour le diagnostic étiologique des oedèmes des membres inférieurs de cause non générale. J Biophys Med Nucl. 1980;4:299–303.
Burnand KM, Glass DM, Mortimer PS, et al. Lymphatic dysfunction in the apparently clinically normal contralateral limbs of patients with unilateral lower limb swelling. Clin Nucl Med. 2012;37:9–13.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
Koo TK, Li MY. A guideline of selecting and reporting Intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–163.
Altman DG. Practical Statistics for Medical Research. Boca Raton, FL: Chapman and Hall/CRC; 1990.
Fleiss JL. The Design and Analysis of Clinical Experiments. New York, NY: Wiley; 1986.
Ebrahim M, Savitcheva I, Axelsson R. Reliability of a scoring system for qualitative evaluation of lymphoscintigraphy of the lower extremities. J Nucl Med Technol. 2017;45:219–224.
Devoogdt N, Van den Wyngaert T, Bourgeois P, et al. Reproducibility of lymphoscintigraphic evaluation of the upper limb. Lymphat Res Biol. 2014;12:175–184.
Jensen MR, Simonsen L, Karlsmark T, et al. The washout rate of a subcutaneous 99mTc-HSA depot in lower extremity lymphoedema. Clin Physiol Funct Imaging. 2012;32:126–132.
Pappalardo M, Cheng MH. Lymphoscintigraphy for the diagnosis of extremity lymphedema: current controversies regarding protocol, interpretation, and clinical application. J Surg Oncol. 2020;121:37–47.
Rockson SG. Advances in lymphedema. Circ Res. 2021;128:2003–2016.
Cheng MH, Pappalardo M, Lin C, et al. Validity of the novel Taiwan lymphoscintigraphy staging and correlation of Cheng lymphedema grading for unilateral extremity lymphedema. Ann Surg. 2018;268:513–525.